Tech Company Financing Transactions
Cadherx Therapeutics Funding Round
Avalon Ventures and private investors participated in a $10 million capital raise for Cadherx Therapeutics. The round was recorded on 6/30/2015.
Transaction Overview
Company Name
Announced On
6/30/2015
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11099 North Torrey Pines Rd. 290
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
CadheRx Therapeutics, Inc. develops therapeutic antibodies targeting soluble E-cadherin (sEcad) for the treatment of tumors that are resistant to other treatments, particularly Cetuximab and Herceptin resistant epithelial cancers. The company was incorporated in 2014 and is based in LA Jolla, California.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Lichter
Browse more venture capital transactions:
Prev: 6/30/2015: Best Option Trading venture capital transaction
Next: 6/30/2015: Synlogic venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs